- United States
- /
- Personal Products
- /
- NYSE:KVUE
Kenvue Second Quarter 2025 Earnings: EPS Misses Expectations
Kenvue (NYSE:KVUE) Second Quarter 2025 Results
Key Financial Results
- Revenue: US$3.84b (down 4.0% from 2Q 2024).
- Net income: US$420.0m (up by US$362.0m from 2Q 2024).
- Profit margin: 11% (up from 1.5% in 2Q 2024).
- EPS: US$0.22 (up from US$0.03 in 2Q 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Kenvue EPS Misses Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 8.3%.
Looking ahead, revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Personal Products industry in the US.
Performance of the American Personal Products industry.
The company's shares are down 4.3% from a week ago.
Risk Analysis
You should always think about risks. Case in point, we've spotted 3 warning signs for Kenvue you should be aware of, and 1 of them is significant.
The New Payments ETF Is Live on NASDAQ:
Money is moving to real-time rails, and a newly listed ETF now gives investors direct exposure. Fast settlement. Institutional custody. Simple access.
Explore how this launch could reshape portfolios
Sponsored ContentValuation is complex, but we're here to simplify it.
Discover if Kenvue might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NYSE:KVUE
Kenvue
Operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America.
Proven track record and fair value.
Similar Companies
Market Insights
Weekly Picks
Early mover in a fast growing industry. Likely to experience share price volatility as they scale

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).

Moderation and Stabilisation: HOLD: Fair Price based on a 4-year Cycle is $12.08
Recently Updated Narratives

An amazing opportunity to potentially get a 100 bagger
Amazon: Why the World’s Biggest Platform Still Runs on Invisible Economics
Sunrun Stock: When the Energy Transition Collides With the Cost of Capital
Popular Narratives

MicroVision will explode future revenue by 380.37% with a vision towards success

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)
